lobeline and s,n,n'-tripropylthiocarbamate

lobeline has been researched along with s,n,n'-tripropylthiocarbamate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bardo, MT; Beckmann, JS; Crooks, PA; Denehy, ED; Dwoskin, LP; Zheng, G	1
Willyard, C	1

Other Studies

2 other study(ies) available for lobeline and s,n,n'-tripropylthiocarbamate

Article	Year
The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats. Psychopharmacology, 2012, Volume: 220, Issue:2 Topics: Animals; Choice Behavior; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Food; Lobeline; Male; Methamphetamine; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Vesicular Monoamine Transport Proteins	2012
Pharmacotherapy: Quest for the quitting pill. Nature, 2015, Jun-25, Volume: 522, Issue:7557 Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins	2015

Article

Year

The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats.

Psychopharmacology, 2012, Volume: 220, Issue:2

Topics: Animals; Choice Behavior; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Food; Lobeline; Male; Methamphetamine; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Vesicular Monoamine Transport Proteins

2012

Pharmacotherapy: Quest for the quitting pill.

Nature, 2015, Jun-25, Volume: 522, Issue:7557

Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins

2015